Exploration Capital, LLC, 10% Owner at Fresh Tracks Therapeutics, Inc. (FRTX), bought 77,404 shares at $0.90 ($69K) on 2024-02-21, disclosed to the SEC on 2024-02-22.
Open-market purchase of $69k FRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.88 | 49,951 | $44K | 64.0% |
| 2 | $0.90 | 22,278 | $20K | 29.2% |
| 3 | $0.90 | 5,175 | $5K | 6.8% |
| Total | $0.89 avg | 77,404 | $69K | 100% |
| Filing → |
| FRTX | BUY | 2024-05-23 | $21K | — | Filing → |
| FRTX | BUY | 2024-05-20 | $136K | — | Filing → |
| FRTX | BUY | 2024-05-08 | $285 | — | Filing → |